The New Zealand Medical Journal is out tomorrow

Editorial

The Government’s proposal to legalise cannabis in New Zealand: 10 key questions
Chris Wilkin, Marta Rychert

Articles

Retrospective analysis of eligibility for denosumab in patients presenting with osteoporotic fractures and renal impairment treated by orthogeriatric service at Middlemore Hospital
Michael Yoon Kang, Jessica Besley, Tina Sun, Sunita Paul

Increasing burden of advanced hepatocellular carcinoma in New Zealand—the need for better surveillance
Cameron Schauer, Thomas Mules, Marius van Rijnsoever, Ed Gane

Cannabis-based medicinal products in arthritis, a painful conundrum
Marthe Van den Berg, Mary John, Melissa Black, Alex Semprini, Karen Oldfield, Michelle Glass, Irene Braithwaite

OPEN ACCESS - Change in smoking intentions of university students in New Zealand following simulated cigarette price increases: results of the first of two cross-sectional surveys
Ben Wamamili

Exploring medicinal use of cannabis in a time of policy change in New Zealand
Marta Rychert, Chris Wilkins, Karl Parker, Thomas Graydon-Guy

OPEN ACCESS -The New Zealand nuclear veteran and families study, exploring the options to assess heritable health outcomes
David McBride, John Dockerty, Robin Turner, Guy Austin, Toby Calvert, Natasha Fasi, Ryder Fuimaono, Timothy Galt, Sam Jackson, Leanda Lepaio, Bill Liu, Darren Ritchie, Nicolas Theis

Attitudes towards cannabis and cannabis law change in a New Zealand birth cohort
Joseph M Boden, Lana Cleland, Bhubaneswor Dhakal, L John Horwood

Viewpoints

The practice of the alcohol industry as health educator: a critique
Nicki Jackson, Rachael Dixon

A balanced opinion? Considering the role of the external clinical advisor in ACC processes
Andrew Dickson, Joanna Manning

OPEN ACCESS - Challenges of virtual talking therapies for substance misuse in New Zealand during the COVID-19 pandemic: an opinion piece
Susanna Galea-Singer, David Newcombe, Virginia Farnsworth-Grodd, Janie Sheridan, Peter Adams, Natalie Walker

OPEN ACCESS - Inhaled modified angiotensin converting enzyme 2 (ACE2) as a decoy to mitigate SARS-CoV-2 infection
Rohan Ameratunga, Klaus Lehnert, Euphemia Leung, Davide Comoletti, Russell Snell, See-Tarn Woon, William Abbott, Emily Mears, Richard Steele, Jeff McKee, Andrew Muscroft-Taylor, Shanthi Ameratunga, Natalie Medlicott, Shyamal Das, William Rolleston, Miguel Quiñones-Mateu, Helen Petousis-Harris, Anthony Jordan

Letters

OPEN ACCESS - Beyond COVID-19: five actions which would improve the health of all New Zealanders
Emma Espiner, Selah Hart, Garth Poole, Tamara Glyn Mullaney, Su Mei Hoh

OPEN ACCESS - Research Letter Survey of public understanding regarding SARS-CoV-2
Roland Crantock

Case Reports

Acute onset internuclear ophthalmoplegia responsive to treatment with intravenous alteplase
Karim M Mahawish, Adarsh Aravind

A memorable case of secondary syphilis
Gerhard Eichhoff, Stephen Hogg

100 Years Ago
Organisation of National Health